145
Views
2
CrossRef citations to date
0
Altmetric
Image Focus

Takotsubo cardiomyopathy triggered by a single dose of flecainide in patient with focal atrial tachycardia

ORCID Icon, ORCID Icon & ORCID Icon
Pages 848-851 | Received 22 May 2021, Accepted 11 Jan 2022, Published online: 24 Jan 2022

References

  • Akashi YJ, Ishihara M. Takotsubo syndrome: insights from Japan. Heart Fail Clin. 2016;12(4):587–595.
  • Di Filippo C, Bacchi B, Di Mario C. Novel aspects of classification, prognosis and therapy in takotsubo syndrome. Eur Cardiol. 2019;14(3):191–196.
  • Templin C, Ghadri JR, Diekmann J, et al. Clinical features and outcomes of takotsubo (stress) cardiomyopathy. N Engl J Med. 2015;373(10):929–938.
  • Kido K, Guglin M. Drug-Induced takotsubo cardiomyopathy. J Cardiovasc Pharmacol Ther. 2017;22(6):552–563.
  • Bodziock G, Armstrong C, Montgomery J. Flecainide overdose presenting with long QT and acute takotsubo cardiomyopathy. J Electrocardiol. 2019;52:7–9.
  • Medina de Chazal H, Del Buono MG, Keyser-Marcus L, et al. Stress cardiomyopathy diagnosis and Treatment: JACC State-of-the-Art Review. J Am Coll Cardiol. 2018;72(16):1955–1971.
  • Aweimer A, El-Battrawy I, Akin I, et al. Abnormal thyroid function is common in takotsubo syndrome and depends on two distinct mechanisms: results of a multicentre observational study. J Intern Med. 2021;289(5):675–687.
  • Gabriel L, Chenu P, Guédès A, et al. A possible association between takotsubo cardiomyopathy and treatment with flecainide. Int J Cardiol. 2011;147(1):173–175.
  • Brugada J, Katritsis DG, Arbelo E, et al. ESC Scientific Document Group. 2019 ESC guidelines for the management of patients with supraventricular tachycardiaThe Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC)). Eur Heart J. 2020;41(5):655–720. Feb 1. https://doi.org/10.1093/eurheartj/ehz467.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.